Da fondaparinux ikke bindes til andre plasmaproteiner end antitrombin, er der ingen forventning om idl
38 Since fondaparinux does not bind significantly to plasma proteins other than antithrombin, no interaction with other medicinal products by protein binding displacement are expected.